Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CFAP206 is a highly conserved protein found across metazoans including humans, mice, and marine invertebrates[1][3]. It contains a DUF3508 domain thought to be involved in cilia and flagella function. CFAP206 is expressed at low levels in various tissues but has relatively higher expression in testis, brain, and respiratory tract, correlating with the presence of motile cilia and sperm flagella[3]. Functional studies show that absence or knockdown of CFAP206 results in defective motile cilia assembly, reduced ciliary beating, decreased sperm motility, and abnormal sperm tail structure, leading to infertility[1]. It is regulated by transcription factors such as Foxj1, which governs ciliogenesis[1]. The protein is cytoplasmic and incorporated into cilia, specifically implicated in radial spoke assembly and the calmodulin-spoke-associated complex, essential for proper ciliary movement and signal transduction[1][3]. There are no known therapeutic interventions targeting CFAP206, but mutations can cause significant disorders, notably primary ciliary dyskinesia and sperm motility defects.
None known. There are no drugs or agents targeting CFAP206.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia- and flagella-associated protein 206 (CFAP206).